Dihidrobenzperidol en es it fr

Dihidrobenzperidol Brand names, Dihidrobenzperidol Analogs

Dihidrobenzperidol Brand Names Mixture

  • No information avaliable

Dihidrobenzperidol Chemical_Formula


Dihidrobenzperidol RX_link


Dihidrobenzperidol fda sheet

Dihidrobenzperidol msds (material safety sheet)

Dihidrobenzperidol MSDS

Dihidrobenzperidol Synthesis Reference

No information avaliable

Dihidrobenzperidol Molecular Weight

166.24 g/mol

Dihidrobenzperidol Melting Point

No information avaliable

Dihidrobenzperidol H2O Solubility

Appreciable as liquid hydrochloride salt

Dihidrobenzperidol State


Dihidrobenzperidol LogP


Dihidrobenzperidol Dosage Forms

Liquid for injection

Dihidrobenzperidol Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Dihidrobenzperidol Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Dihidrobenzperidol Absorption

Rapidly absorbed.

Dihidrobenzperidol side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Dihidrobenzperidol Patient Information

No information avaliable

Dihidrobenzperidol Organisms Affected

Humans and other mammals